NMPA Approval

Human Erythropoietin Injection

Approval Number

国药准字S20227003

Registration Date

January 28, 2022

Previous Approval Numbers

国药准字S20000008国药准字S20103002国药准字S20133020国药准字S20133002国药准字S20133003

Drug Information

Generic Name

人促红素注射液

Trade Name

依普定

Dosage Form

注射剂

Strength

36000IU/1ml/支

Drug Type

生物制品

Registration Date

January 28, 2022

Company Address

山东省济南市章丘区明水开发区创业路2666号

Company Address

山东省济南市章丘区埠村街道创业路2666号

Empowering clinical research with data-driven insights and AI-powered tools.

人促红素注射液 - NMPA 批准文号 | MedPath